Cargando…
Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology—Molecular docking—Key target validation"
OBJECTIVE: To explore the potential mechanism of Shenkang injection (SKI) in the treatment of chronic renal failure based on network pharmacology and molecular docking technology, and to verify the core targets and key pathways by using the renal failure model. METHODS: The active components and tar...
Autores principales: | Zhou, Lin, Wang, Xiaohui, Sun, Zhi, Bao, Xiaoyue, Xue, Lianping, Xu, Zhanmei, Dong, Pengfei, Xia, Jinlan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553805/ https://www.ncbi.nlm.nih.gov/pubmed/37796994 http://dx.doi.org/10.1371/journal.pone.0291621 |
Ejemplares similares
-
Pharmacokinetics and Metabolism Research of Shenkang Injection in Rats Based on UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS
por: Jiang, Xiaofang, et al.
Publicado: (2020) -
Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats
por: Chen, Rongchang, et al.
Publicado: (2022) -
Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis
por: Xie, Feng, et al.
Publicado: (2023) -
Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: A protocol of a randomized controlled trial
por: Mei, JuXiang, et al.
Publicado: (2021) -
ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway
por: Wei, Hui-Ting, et al.
Publicado: (2022)